miRNA-92a-3p regulates osteoblast differentiation in patients with concomitant limb fractures and TBI via IBSP/PI3K-AKT inhibition

miRNA-92a-3p regulates osteoblast differentiation in patients with concomitant limb fractures and TBI via IBSP/PI3K-AKT inhibition

miRNA-92a-3p regulates osteoblast differentiation in patients with concomitant limb fractures and TBI via IBSP/PI3K-AKT inhibition

Sufferers who maintain concomitant fractures and traumatic mind harm (TBI) are identified to have considerably faster fracture-healing charges than sufferers with remoted fractures. The mechanisms underlying this phenomenon have but to be recognized. Within the current examine, we discovered that the upregulation of microRNA-92a-3p (miRNA-92a-3p) induced by TBI correlated with a lower in integrin binding sialoprotein (IBSP) expression in callus formation. In vitro, overexpressing miRNA-92a-3p inhibited IBSP expression and accelerated osteoblast differentiation, whereas silencing of miRNA-92a-3p inhibited osteoblast exercise.
A lower in IBSP facilitated osteoblast differentiation through the Phosphatidylinositol 3-kinase/threonine kinase 1 (PI3K/AKT) signaling pathway. By way of luciferase assays, we discovered proof that IBSP is a miRNA-92a-3p goal gene that negatively regulates osteoblast differentiation. Furthermore, the current examine confirmed that pre-injection of agomiR-92a-3p results in elevated bone formation. Collectively, these outcomes point out that miRNA-92a-3p overexpression could also be a key issue underlying the improved fracture therapeutic noticed in TBI sufferers. Upregulation of miRNA-92a-3p could due to this fact be a promising therapeutic technique for selling fracture therapeutic and stopping nonunion.

EZH2-miRNA Optimistic Suggestions Promotes Tumor Progress in Ovarian Most cancers

Enhancer of zester homolog 2 (EZH2), a histone methyl transferase that mediates H3K27me3 via polycomb repressive complicated 2 (PRC2), is overexpressed in ovarian most cancers and promotes malignant proliferation. Nevertheless, the underlying mechanism of sustaining excessive EZH2 expression stays elusive. Right here we confirmed that microRNA(miRNA) inhibited EZH2 by binding to the three’-UTR of EZH2 mRNA; conversely, EZH2 can inhibit miRNA expression. We confirmed {that a} suggestions loop exists between EZH2 and miRNA that maintained EZH2 overexpression, thus selling ovarian most cancers proliferation in vivo and in vitro.
We additional explored that EZH2 inhibited miRNA expression via PRC2, as decided by CHIP (chromatin immunoprecipitation), and EZH2 decreased the expression of p21, p53, and RUNX3. These outcomes counsel that EZH2 inhibits the expression of Et-miRNAs (EZH2-targeting miRNAs) via the H3K27me3 pathway, thus forming an EZH2-miRNA constructive suggestions loop that maintains the excessive expression of EZH2 and promotes the malignant proliferation of most cancers cells by regulating the expression of cell proliferation-related proteins.

Extracellular Vesicle-Related miRNAs as a Biomarker for Lung Most cancers in Liquid Biopsy

Extracellular vesicles are cell-derived membranous vesicles which might be secreted into biofluids. Rising proof means that EVs play a vital function within the pathogenesis of many illnesses by transferring proteins, genetic materials, and small signaling molecules between cells. Amongst these molecules, microRNAs (miRNAs), a sort of small noncoding RNA, are one of the vital necessary indicators and are concerned in numerous organic processes. Lung most cancers is likely one of the main causes of cancer-related deaths worldwide.
Early analysis of lung most cancers could assist to scale back mortality and enhance the 5 years survival fee and thereby scale back the related socioeconomic burden. Up to now, EV-miRNAs have been acknowledged as biomarkers of a number of cancers to help in analysis or prognosis. On this assessment, we talk about latest findings and scientific observe for EV-miRNAs of lung most cancers in a number of biofluids, together with blood, bronchoalveolar lavage fluid (BALF), and pleural lavage.

Ultrasensitive Detection of Nasopharyngeal Carcinoma-Associated MiRNA via Garland Rolling Circle Amplification Built-in Catalytic Hairpin Meeting

MiRNA is reported to be carefully associated to nasopharyngeal carcinoma and has the potential to be a biomarker for the early analysis of nasopharyngeal carcinoma. Nevertheless, the detection of miRNAs stays to be improved, given their complexity and low sensitivity. Herein, we suggest right here a novel miRNA detection technique via the combination of garland RCA and CHA. Intimately, the strategy consists of two necessary sign amplification processes.
For the primary sign amplification course of, the goal miRNA may provoke garland RCA after which generate a nicking website on the merchandise with the help of Nb.BbvCI enzymes. Afterward, a CHA course of is induced with a designed H probe via the 2 sign amplification processes; the strategy exhibited a much-improved sensitivity. Eventually, we imagine that this technique is a promising strategy able to being utilized in screening, diagnosing, and prognosticating a number of illnesses.
miRNA-92a-3p regulates osteoblast differentiation in patients with concomitant limb fractures and TBI via IBSP/PI3K-AKT inhibition

Identification of exosome miRNAs in bronchial epithelial cells after PM2.5 continual publicity

Quite a few epidemiological research have demonstrated that continual PM2.5 publicity was related to the lung carcinogenesis with out identified potential mechanisms. Exosomes-derived non-coding RNAs, together with miRNAs, are proposed to play crucial function within the incidence and growth of malignant illnesses. So identification of exosomes-derived miRNAs may assist us to higher perceive the molecular toxicity of PM2.5-induced lung most cancers. Institution continual publicity animal and cell mannequin with PM2.5 was carried out as earlier than. HE staining was used for estimating the histological alternations of lungs in vivo. The expressions of EMT markers in vivo and vitro have been quantified by Western blot. Then the exosomes in cell tradition supernatant have been extracted and the concerned miRNAs have been extracted and sequenced. The totally different expression stage of miRNAs have been verified by RT-PCR.
Persistent PM2.5 publicity induced bronchial epithelial cell atypical hyperplasia and big macrophage infiltration. PM2.5 publicity induce EMT occasion in vivo and vitro indicated as elevated expression of Vimentin and decreased expression of E-cadherin. And 5 passages of PM2.5 stimulation additionally induced the discharge of wealthy and extractable exosomes within the cell tradition supernatant in vitro. By way of sequencing, there have been differentially expressed 36 miRNAs between PM2.5 continual uncovered and management teams with 1.5-fold and higher variations.
Amongst them, there have been 30 exosome-miRNAs upregulated and 6 downregulated expression by PM2.5 publicity. The downregulated expression of miR-29b-2-5p, miR-193b-5p and miR-320c and upregulated expression of miR-100-5p, 125b-5p and unconservative_2_45093 in PM2.5 group have been recognized and reconfirmed by qRT-PCR. Persistent PM2.5 publicity causes bronchial epithelial cells atypical hyperplasia and induces EMT occasion in vivo, and it additionally induce the expression variations of miRNAs in exosome in vitro.

Kidney Lysate

21-190 0.1 mg
EUR 342.6
Description: Monkey (Cynomolgus) kidney tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The monkey (Cynomolgus) kidney tissue total protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the kidney tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The kidney tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Kidney Lysate

21-405 0.1 mg
EUR 342.6
Description: Porcine kidney tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The porcine kidney tissue total protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the kidney tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The kidney tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Kidney Lysate

21-418 0.1 mg
EUR 342.6
Description: Rabbit kidney tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The rabbit kidney tissue total protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the kidney tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The kidney tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Mouse Kidney PrimaCell2: Normal Kidney Epithelial Cells

2-82057 1 Kit Ask for price

Rat Kidney PrimaCell2: Normal Kidney Epithelial Cells

2-82556 1 Kit Ask for price

Multiple kidney tumor with kidney tissue array

KD1501a each
EUR 258
Description: Multiple kidney tumor with kidney tissue array, including pathology grade, TNM and clinical stage (reference AJCC 7th version), 75 cases/150 cores, replacing KD1501

Kidney carcinoma with matched kidney tissue array

KD244a each
EUR 48
Description: Kidney carcinoma with matched kidney tissue array, including pathology grade, TNM and clinical stage, 12 cases/24 cores, replacing KD244

Kidney cancer with matched kidney tissue array

KD801a each
EUR 258
Description: Kidney cancer with matched kidney tissue array, including pathology grade, TNM and clinical stagr, 40 cases/80 cores, replacing KD801

Human Kidney Tissue Preparation Buffer 2: Normal Kidney Epithelial Cells

9-80075 1 x 100 ml Ask for price

MicroRNA Isolation Kit

KS341025 1 kit
EUR 307.2
Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation.

Autobioluminescent Human Kidney Cells (HEK293)

ASE-5902 1 ml
EUR 2004
Description: 6 month

Kidney disease spectrum (kidney cancer progression) tissue array

BC07001 each
EUR 258
Description: Kidney disease spectrum (kidney cancer progression) tissue array, including TNM and pathology grade, 40 cases/80 cores (core size 1.5mm)

Kidney cancer tissue array with normal Kidney tissue

KD2082a each
EUR 474
Description: Kidney cancer tissue array with normal Kidney tissue, including TNM and pathology grade, 96 cases/192 cores, replacing KD2082

Multiple kidney cancer with matched kidney tissue array

KD461 each
EUR 258
Description: Multiple kidney cancer with matched kidney tissue array, including pathology grade, TNM and clinical stage, 23 cases/46 cores

Normal kidney and normal adjacent kidney tissue array

KDN241a each
EUR 138
Description: Normal kidney and normal adjacent kidney tissue array, 24 cases/ 24 cores

Kidney cancer with kidney tissue test tissue array

T071b each
EUR 48
Description: Kidney cancer with kidney tissue test tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T071a

Kidney Lupus Lysate

XBL-10357 0.1 mg
EUR 796.2
Description: Human kidney tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human kidney tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the kidney tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The kidney tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Fetal Kidney Lysate

XBL-10408 0.1 mg
EUR 342.6
Description: Fetal human kidney tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The fetal human kidney tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the kidney tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The kidney tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Kidney Membrane Lysate

XBL-10649 0.1 mg
EUR 619.8
Description: Human kidney tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human kidney tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated kidney tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated kidney tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal.

Kidney cancer (CCRCC

KD1201 each
EUR 306
Description: Kidney cancer (CCRCC,PRCC,CRCC)with kidney tissue array,including ISUP Grade, TNM/Stage, 120 cases/120 cores (core size 1.0mm ), (Previous Item# is BC07115b)

Kidney tissue array

KD803b each
EUR 354
Description: Kidney tissue array, 80 cases/80n cores (core size 1.5mm), replacing KD803a

Rat Kidney PrimaCell2: Normal Kidney Epithelial Cells Growth Medium

9-25056 5 x 100 ml Ask for price

Mouse Kidney PrimaCell2: Normal Kidney Epithelial Cells Growth Medium

9-32057 5 x 100 ml Ask for price

Kidney cancer tissue array with adjacent normal kidney tissue

BC07015b each
EUR 168
Description: Kidney cancer tissue array with adjacent normal kidney tissue, including TNM, clinical stage and pathology grade, 72 cases/72 cores, replacing BC07015a

Kidney cancer with matched adjacent normal kidney tissue array

KD603 each
EUR 204
Description: Kidney cancer with matched adjacent normal kidney tissue array, containing metastatic clear cell carcinoma, including pathology grade, TNM and clinical stage (reference AJCC 8th version), 33 cases/61 cores

Human microRNA-210(miR-210)ELISA

QY-E05678 96T
EUR 433.2

hsa-miRNome MicroRNA Profiling Kit [Human]

RA660A-1 20 profiles
EUR 2212.8

Recombinant Human Kidney Associated Antigen 1

7-05422 1µg Ask for price

Recombinant Human Kidney Associated Antigen 1

7-05423 5µg Ask for price

Recombinant Human Kidney Associated Antigen 1

7-05424 50µg Ask for price

Human Kidney OptiTDS1: Tissue Dissociation System

4-28074 1 Kit Ask for price

Human Kidney OptiTDS2: Tissue Dissociation System

4-28075 1 Kit Ask for price

Human Kidney OptiTDS3: Tissue Dissociation System

4-28076 1 Kit Ask for price

Human Kidney OptiTDS4: Tissue Dissociation System

4-28077 1 Kit Ask for price

Human Kidney OptiTDS5: Tissue Dissociation System

4-28078 1 Kit Ask for price

Human Kidney OptiTDS6: Tissue Dissociation System

4-28079 1 Kit Ask for price

Human Kidney OptiTDS7: Tissue Dissociation System

4-28080 1 Kit Ask for price

Human Cancer PrimaCell9: Kidney Tumor Cells

2-96032 1 Kit Ask for price

Human Kidney PrimaCell4: Normal Renal Firbroblasts

2-96077 1 Kit Ask for price

Human Kidney PrimaCell6: Normal Renal Podocytes

2-96079 1 Kit Ask for price

Human Glutaminase kidney isoform, mitochondrial (GLS)

1-CSB-EP009528HU(F)
  • EUR 606.00
  • EUR 318.00
  • EUR 2192.40
  • EUR 919.20
  • EUR 1461.60
  • EUR 402.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Human Glutaminase kidney isoform, mitochondrial(GLS),partial expressed in E.coli

Human Glutaminase kidney isoform, mitochondrial (GLS)

1-CSB-EP009528HU(F1)
  • EUR 606.00
  • EUR 318.00
  • EUR 2192.40
  • EUR 919.20
  • EUR 1461.60
  • EUR 402.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Human Glutaminase kidney isoform, mitochondrial(GLS),partial expressed in E.coli

cDNA from Human Tumor Tissue: Kidney

C1235142 40 reactions
EUR 648
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

cDNA from Human Diabetic Tissue: Kidney

C1236142Dia 40 reactions
EUR 801.6
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Paraffin Tissue Section - Human Kidney Tumor

T2235142 5 slides
EUR 308.4
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool.

Frozen Tissue Section - Human Tumor: Kidney

T1235142 5 slides
EUR 405.6
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool.

Cancer MicroRNA qPCR Array

RA610A-1 10 profiles
EUR 1406.4

Mouse Kidney Tissue Preparation Buffer 2: Normal Kidney Epithelial Cells

9-80171 1 x 100 ml Ask for price

Rat Kidney Tissue Preparation Buffer 2: Normal Kidney Epithelial Cells

9-80263 1 x 100 ml Ask for price

Kidney cancer tissue array with matched cancer adjacent kidney tissue

KD2601a each
EUR 354
Description: Kidney cancer tissue array with matched cancer adjacent kidney tissue,including TNM, clinical stage and pathology grade, 65 cases/ 260 cores, replacing KD2061

Kidney tumor tissue array with matched tumor adjacent kidney tissue

KD2602a each
EUR 354
Description: Kidney tumor tissue array with matched tumor adjacent kidney tissue, including TNM, clinical stage and pathology grade, 65 cases/260 cores, replacing KD2602

Kidney clear cell carcinoma with matched adjacent kidney tissue array

KD486 each
EUR 168
Description: Kidney clear cell carcinoma with matched adjacent kidney tissue array, including TNM and pathology grade, 16 cases/48 cores

Kidney cancer tissue array with matched adjacent normal kidney tissue

KD901a each
EUR 258
Description: Kidney cancer tissue array with matched adjacent normal kidney tissue, including TNM, clinical stage and pathology grade, 40 cases/90 cores, replacing KD901

Kidney Tissue Slide (Normal)

10-401-10um 10 um
EUR 241.8

Kidney Tissue Slide (Normal)

10-401-4um 4 um
EUR 216.6

Kidney Tissue Slide (Tumor)

10-402-10um 10 um
EUR 241.8

Kidney Tissue Slide (Tumor)

10-402-4um 4 um
EUR 216.6

Kidney Tissue Slide (Abnormal)

10-455-10um 10 um
EUR 241.8

Kidney Tissue Slide (Abnormal)

10-455-4um 4 um
EUR 216.6

Kidney Tissue Lysate (Normal)

1706-02 0.1 mg
EUR 260.7
Description: Kidney tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Kidney Tissue Lysate (Normal)

1706-03 0.1 mg
EUR 260.7
Description: Kidney tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Kidney Tissue Lysate (Normal)

1706-04 0.1 mg
EUR 260.7
Description: Kidney tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Kidney Tissue Lysate (Normal)

1706-05 0.1 mg
EUR 260.7
Description: Kidney tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Kidney Tissue Lysate (Tumor)

1707-01 0.1 mg
EUR 336.3
Description: Kidney tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Kidney Tissue Lysate (Tumor)

1707-02 0.1 mg
EUR 336.3
Description: Kidney tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Kidney Tissue Lysate (Tumor)

1707-03 0.1 mg
EUR 336.3
Description: Kidney tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Kidney Tissue Lysate (Tumor)

1707-04 0.1 mg
EUR 336.3
Description: Kidney tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Kidney Tissue Lysate (Tumor)

1707-05 0.1 mg
EUR 336.3
Description: Kidney tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Kidney Tissue Lysate (Tumor)

1707-06 0.1 mg
EUR 336.3
Description: Kidney tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Kidney Tissue Lysate (Tumor)

1707-07 0.1 mg
EUR 336.3
Description: Kidney tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Kidney Tissue Lysate (Tumor)

1707-08 0.1 mg
EUR 336.3
Description: Kidney tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Kidney Tissue Lysate (Tumor)

1707-09 0.1 mg
EUR 336.3
Description: Kidney tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Kidney Tissue Lysate (Tumor)

1708-01 0.1 mg
EUR 336.3
Description: Kidney tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Kidney Tissue Lysate (Tumor)

1708-02 0.1 mg
EUR 336.3
Description: Kidney tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Kidney Tissue Lysate (Tumor)

1708-03 0.1 mg
EUR 336.3
Description: Kidney tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Kidney Tissue Lysate (Tumor)

1709-01 0.1 mg
EUR 336.3
Description: Kidney tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Kidney Tissue Lysate (Tumor)

1709-02 0.1 mg
EUR 336.3
Description: Kidney tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Kidney Tissue Lysate (Tumor)

1709-03 0.1 mg
EUR 336.3
Description: Kidney tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

cDNA from hypertension: Kidney

C1236142Hd-2 40 reactions
EUR 801.6
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

cDNA from Lupus: Kidney

C1236142Lup 40 reactions
EUR 801.6
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Rat Kidney Tissue Lysate

LYSATE0006 200ug
EUR 180
Description: This cell lysate is prepared from rat kidney tissue using Boster's RIPA Lysis Buffer (AR0105) using a standard whole cell lysate protocol. The concentration was determined using the BCA assay process and then diluted using Dithiothreitol (DTT) and a reducing SDS sample loading buffer, heated for 5 minutes at 100˚C.

Mouse Kidney Tissue Lysate

LYSATE0016 200ug
EUR 180
Description: This cell lysate is prepared from mouse kidney tissue using Boster's RIPA Lysis Buffer (AR0105) using a standard whole cell lysate protocol. The concentration was determined using the BCA assay process and then diluted using Dithiothreitol (DTT) and a reducing SDS sample loading buffer, heated for 5 minutes at 100˚C.

Plastic Kidney Bowl 252mm

INS6272 EACH
EUR 6.84

Kidney Liver Cirrhosis Lysate

XBL-10356 0.1 mg
EUR 796.2
Description: Human kidney tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human kidney tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the kidney tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The kidney tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Fetal Kidney Cytoplasmic Lysate

XBL-10657 0.1 mg
EUR 273.3
Description: Human kidney tissue cytoplasmic protein lysate was prepared by isolating the cytoplasmic protein from whole tissue homogenates using a proprietary technique. The fetal human kidney tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The cytoplasmic protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, glycerol, and a cocktail of protease inhibitors. For quality control purposes, the isolated kidney tissue cytoplasmic protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated kidney tissue cytoplasmic protein is then Western analyzed by GAPDH antibody, and the expression level is consistent with each lot.

Kidney Membrane Tumor Lysate

XBL-10661 0.1 mg
EUR 752.1
Description: Human kidney tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human kidney tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated kidney tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated kidney tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal.

Mouse Kidney Nuclear Extract

X12011 500 µg Ask for price

Kidney cancer tissue array

BC07014b each
EUR 168
Description: Kidney cancer tissue array, including pathology grade, TNM and clinical stage, 72 cases/72 cores, replacing BC07014a

Kidney cancer tissue array

KD245 each
EUR 66
Description: Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 24 cases/ 24 cores

Kidney cancer tissue array

KD485 each
EUR 168
Description: Kidney cancer tissue array, with normal tissue, including TNM and pathology grade, 48 cases/48 cores

Normal kidney tissue array

KD803 each
EUR 354
Description: Normal kidney tissue array, replacing BN07012, 80 cases/80 cores

Normal kidney tissue array

KDN242 each
EUR 72
Description: Normal kidney tissue array, 24 cases/24 cores

Human pre-microRNA Expression Construct 146a-2

PMIRH146a-PA-2 Bacterial Streak
EUR 820.8

Human pre-microRNA Expression Construct Lentimir-29a

PMIRH29aPA-2 Bacterial Streak
EUR 820.8

Human pre-microRNA Expression Construct let-7b

PMIRHlet7bPA-1 Bacterial Streak
EUR 820.8

Human pre-microRNA Expression Construct let-7c

PMIRHlet7cPA-1 Bacterial Streak
EUR 820.8

Human pre-microRNA Expression Construct let-7d

PMIRHlet7dPA-1 Bacterial Streak
EUR 820.8

Human pre-microRNA Expression Construct let-7e

PMIRHlet7ePA-1 Bacterial Streak
EUR 820.8

Human pre-microRNA Expression Construct let-7g

PMIRHlet7gPA-1 Bacterial Streak
EUR 820.8

Human pre-microRNA Expression Construct let-7i

PMIRHlet7iPA-1 Bacterial Streak
EUR 820.8

Multiple kidney cancer with matched tumor adjacent (AT) kidney tissue array

KD702a each
EUR 234
Description: Multiple kidney cancer with matched tumor adjacent (AT) kidney tissue array, 35 cases/70 cores, including CCRCC (15 cases), PRCC (9 cases), CHRCC (8 cases), ccpRCC (3 cases)

Multiple kidney disease with kidney tissue array (2016/ISUP WHO classification

KD804a each
EUR 258
Description: Multiple kidney disease with kidney tissue array (2016/ISUP WHO classification, Grade mean Isup Grade), including pathoogy grade, TNM and clinical stage (reference AJCC 8th version), 75 cases/80 cores, replacing KD804

Human Kidney PrimaCell1: Normal Glomerular Endothelial Cells

2-96074 1 Kit Ask for price

Human Kidney PrimaCell5: Normal Renal Mesangial Cells

2-96078 1 Kit Ask for price

Human Kidney PrimaCell 8: Proximal Tubular Cells

2-96120 1 Kit Ask for price

Human Kidney Injury Molecule 1 (Kim1) Protein

20-abx168665
  • EUR 644.40
  • EUR 292.80
  • EUR 1880.40
  • EUR 760.80
  • EUR 477.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Human Kidney Injury Molecule 1 (Kim1) Protein

20-abx067643
  • EUR 644.40
  • EUR 292.80
  • EUR 1880.40
  • EUR 760.80
  • EUR 477.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Human Kidney mitochondrial carrier protein 1 (SLC25A30)

1-CSB-EP732909HU
  • EUR 456.00
  • EUR 256.80
  • EUR 1570.80
  • EUR 672.00
  • EUR 1047.60
  • EUR 314.40
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Human Kidney mitochondrial carrier protein 1(SLC25A30) expressed in E.coli

cDNA from Human Adult Normal Tissue: Kidney

C1234142 40 reactions
EUR 451.2
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Human Kidney Injury Molecule 1 ELISA kit

E01K0025-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Human Kidney Injury Molecule 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Kidney Injury Molecule 1 ELISA kit

E01K0025-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Human Kidney Injury Molecule 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Kidney Injury Molecule 1 ELISA kit

E01K0025-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Human Kidney Injury Molecule 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Liver kidney microsome autoantibody ELISA kit

E01L0238-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Human Liver kidney microsome autoantibody in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Liver kidney microsome autoantibody ELISA kit

E01L0238-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Human Liver kidney microsome autoantibody in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Liver kidney microsome autoantibody ELISA kit

E01L0238-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Human Liver kidney microsome autoantibody in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Total Protein from Human Tumor Tissue: Kidney

P1235142 1 mg
EUR 384
Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation.

Total Protein from Human Diabetic Tissue: Kidney

P1236142Dia 1 mg
EUR 553.2
Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation.

Human Adult Kidney (Normal) Whole tissue lysate

HAL-1305 1 mg
EUR 628.8

Human 293, transformed primary embryonal kidney lysate

HCL-1210 100ug
EUR 255.6

Human Kidney Slide (Normal) (5 slides/pk)

HTS-10401 1 pk
EUR 343.2

Human Kidney Slide (Tumor) (5 slides/pk)

HTS-10402 1 pk
EUR 343.2

Human Kidney Slide (Abnormal) (5 slides/pk)

HTS-10455 1 pk
EUR 343.2

Human liver kidney microsome autoantibody ELISA Kit

ELA-E1133h 96 Tests
EUR 988.8

Membrane Protein from Human Tumor Tissue: Kidney

P3235142 0.1 mg
EUR 489.6
Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation.

Paraffin Tissue Section - Human Adult Normal: Kidney

T2234142 5 slides
EUR 253.2
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool.

Frozen Tissue Section - Human Adult Normal: Kidney

T1234142 5 slides
EUR 418.8
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool.

Frozen Tissue Section - Human Diabetic Tissue: Kidney

T1236142Dia 5 slides
EUR 558
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool.

Total RNA from Human Tumor Tissue: Kidney

R1235142-50 50 ug
EUR 421.2
Description: Can be used for various studies in the realm of gene expression and regulation, both normal and pathological. It is an excellent control and suitable for educational purposes.

Human Cadherin, Fetal Kidney(KCAD)ELISA Kit

QY-E01335 96T
EUR 433.2

MicroRNA scramble in CD511 - Virus

PMIRH000VA-1 1x10^6 IFUs
EUR 937.2

MicroRNA Precursor Pooled Plasmid Library

PMIRHPLPA-1 1 aliquot plasmid DNA
EUR 60

SanPrep Column microRNA Miniprep Kit

SK8811 50prep
EUR 151.32

Stem Cell MicroRNA Profiling Panel

RA620A-1 10 profiles
EUR 1406.4

Human Kidney PrimaCell2: Normal Kidney Epithelial Cells Growth Supplements with Serum (for 500 ml medium)

9-47075 1 Set Ask for price

Kidney cancer (grade I) tissue array with matched adjacent normal kidney tissue

KD701a each
EUR 234
Description: Kidney cancer (grade I) tissue array with matched adjacent normal kidney tissue, including TNM, clinical stage and pathology grade, 35 cases/70 cores, replacing KD701

Pig WHOLE KIDNEY 10 EA*

59420-2 10 EA
EUR 285.49

Bovine KIDNEY WHOLE 2 EA*

57120-2 2 EA
EUR 209.81

Kidney Lysate (0 Days Old)

1405-0 0.1 mg
EUR 229.2
Description: Kidney tissue lysate (0 Days Old) was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

Kidney Lysate (14 Days Old)

1405-14 0.1 mg
EUR 229.2
Description: Kidney tissue lysate (14 Days Old) was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

Kidney Lysate (7 Days Old)

1405-7 0.1 mg
EUR 229.2
Description: Kidney tissue lysate (7 Days Old) was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

CK KIDNEY WHOLE 25 EA*

43020-2 25 EA
EUR 288.11

Rabbit KIDNEY WHOLE 50 EA

41220-2 50 Each
EUR 234.6

Mouse Kidney PrimaCell3: Normal Podocytes

2-82058 1 Kit Ask for price

Rat Kidney Medulla Tissue Lysate

30R-AK004 150 ug
EUR 230.4
Description: Fresh tissue lysate isolated from the medulla of rat kidney

Kidney-Type Arginase Recombinant Protein

92-034 0.05 mg
EUR 651.3
Description: Kidney-Type Arginase (ARG2) is a member of the arginase family. Arginase is a manganese-containing enzyme which catalyzes the hydrolysis of arginine to ornithine and urea. ARG2 is highly expressed in kidney and prostate, not founded in the liver, heart and pancreas. ARG2 has been implicated in the regulation of the arginine/ornithine concentrations in the cell. ARG2 may take part in the regulation of extra-urea cycle arginine metabolism and in down-regulation of nitric oxide synthesis. The extrahepatic arginase functions to regulate L-arginine bioavailability to NO synthase.

Kidney Associated Antigen 1 Protein

20-abx263415
  • EUR 276.00
  • EUR 1930.80
  • EUR 393.60
  • 1 µg
  • 50 ug
  • 5 ug

cDNA from Liver Cirrhosis: Kidney

C1236142Lcs 40 reactions
EUR 801.6
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Mouse Kidney Whole tissue lysate

MAL-1405 1 mg
EUR 628.8

Total Protein from Lupus: Kidney

P1236142Lup 1 mg
EUR 553.2
Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation.

Membrane Protein from Lupus: Kidney

P3236142Lup 0.1 mg
EUR 489.6
Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation.

Paraffin Tissue Section - Lupus: Kidney

T2236142Lup 5 slides
EUR 298.8
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool.

Immortalized Equine Kidney Cells (extEqFK)

T0084 1x106 cells / 1.0 ml Ask for price

Frozen Tissue Section - hypertension: Kidney

T1236142Hd-2 5 slides
EUR 558
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool.

Frozen Tissue Section - Lupus: Kidney

T1236142Lup 5 slides
EUR 640.8
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool.

Total RNA from Lupus: Kidney

R1236142Lup-50 50 ug
EUR 421.2
Description: Can be used for various studies in the realm of gene expression and regulation, both normal and pathological. It is an excellent control and suitable for educational purposes.

Rat Kidney Whole tissue lysate

RAL-1465 1 mg
EUR 628.8

Kidney cancer survey tissue array

KD2085 each
EUR 474
Description: Kidney cancer survey tissue array, no overlapping with KD2089, including TNM, clinical stage and pathology grade, 104 cases/208 cores

Kidney cancer survey tissue array

KD2089 each
EUR 474
Description: Kidney cancer survey tissue array, no overlapping with KD2085, including TNM and pathology grade, 104 cases/208 cores

Kidney cancer test tissue array

T072b each
EUR 48
Description: Kidney cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing T072a

Rat normal kidney tissue array

TR071a each
EUR 48
Description: Rat normal kidney tissue array, 6 cases/24 cores, replacing TR071

Human pre-microRNA Expression Construct Lenti-miR-100

PMIRH100PA-1 Bacterial Streak
EUR 820.8

Human pre-microRNA Expression Construct Lenti-miR-106a

PMIRH106aPA-1 Bacterial Streak
EUR 820.8

Human pre-microRNA Expression Construct Lenti-miR-106b

PMIRH106bPA-1 Bacterial Streak
EUR 820.8

Human pre-microRNA Expression Construct Lenti-miR-107

PMIRH107PA-1 Bacterial Streak
EUR 820.8

Human pre-microRNA Expression Construct Lenti-miR-10a

PMIRH10aPA-1 Bacterial Streak
EUR 820.8

Human pre-microRNA Expression Construct Lenti-miR-10b

PMIRH10bPA-1 Bacterial Streak
EUR 820.8

Human pre-microRNA Expression Construct Lenti-miR-1178

PMIRH1178PA-1 Bacterial Streak
EUR 820.8

Human pre-microRNA Expression Construct Lenti-miR-1179

PMIRH1179PA-1 Bacterial Streak
EUR 820.8

Human pre-microRNA Expression Construct Lenti-miR-1180

PMIRH1180PA-1 Bacterial Streak
EUR 820.8

Human pre-microRNA Expression Construct Lenti-miR-1181

PMIRH1181PA-1 Bacterial Streak
EUR 820.8

Human pre-microRNA Expression Construct Lenti-miR-1182

PMIRH1182PA-1 Bacterial Streak
EUR 820.8

Human pre-microRNA Expression Construct Lenti-miR-1183

PMIRH1183PA-1 Bacterial Streak
EUR 820.8

Human pre-microRNA Expression Construct Lenti-miR-1184

PMIRH1184PA-1 Bacterial Streak
EUR 820.8

Human pre-microRNA Expression Construct Lenti-miR-1197

PMIRH1197PA-1 Bacterial Streak
EUR 820.8

Human pre-microRNA Expression Construct Lenti-miR-1200

PMIRH1200PA-1 Bacterial Streak
EUR 820.8

Human pre-microRNA Expression Construct Lenti-miR-1202

PMIRH1202PA-1 Bacterial Streak
EUR 820.8
In the meantime, the recognized differentially expressed exosome-miRNAs could partially affiliate with tumorigenesis. To sum up, the recognized exosome-miRNAs could play function within the growth of lung most cancers induced by continual PM2.5 publicity.

Leave a Reply

Your email address will not be published. Required fields are marked *